While COPCOV suggests a modest signal in prophylaxis (RR ~0.85, borderline significance) [ 5 ], this effect is small, non‐clinically relevant (1% vs. 1.2%), and inconsistently observed across trials.
← all excerpts
Reply to "Preclinical and Clinical Evidence on Chloroquine or Hydroxychloroquine in COVID-19": Achieving Statistical Significance Does Not Mean That Clinical Relevance Can Be Disregarded, and This Must Be Considered When Interpreting Results.
1
—
—